Fatal pulmonary veno-occlusive disease possibly related to gemcitabine

Lung Cancer

Volumn 31, Issue 1, 2001, Pages 83-85

  Vansteenkiste, Johan F ^a   Bomans, Peter ^a   Verbeken, Eric K ^a   Nackaerts, Kris L ^a   Demedts, Maurits G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinoma, non small cell lung; Case report; Gemcitabine; Pulmonary toxicity; Veno occlusive disease

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; VINDESINE;

ADULT; ARTICLE; CASE REPORT; DYSPNEA; FATALITY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG EDEMA; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; LUNG VEIN OBSTRUCTION; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DYSPNEA; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY VENO-OCCLUSIVE DISEASE;

EID: 0035204535     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00159-8     Document Type: Article

References (8)

1. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review
2. A phase II study of docetaxel alternating with cisplatin in chemonaive patients with advanced non-small cell lung cancer
3. Veno-occlusive disease of the liver induced by gemcitabine [letter]
4. Fatal pulmonary toxicity resulting from treatment with gemcitabine
5. Hemolytic uremic syndrome caused by gemcitabine [letter]
6. Pulmonary veno-occlusive disease after chemotherapy
7. Pulmonary veno-occlusive disease following therapy for malignant neoplasms
8. Single lung transplantation: replacement therapy for end-stage lung disease